Quoin Pharmaceuticals Stock (NASDAQ:QNRX)
Previous Close
$13.40
52W Range
$5.01 - $48.30
50D Avg
$9.12
200D Avg
$9.43
Market Cap
$7.62M
Avg Vol (3M)
$306.36K
Beta
1.86
Div Yield
-
QNRX Company Profile
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
QNRX Performance
Peer Comparison
| Ticker | Company |
|---|---|
| RADX | Radiopharm Theranostics Limited |
| OSRH | OSR Holdings, Inc. |
| CELZ | Creative Medical Technology Holdings, Inc. |
| APVO | Aptevo Therapeutics Inc. |
| KPRX | Kiora Pharmaceuticals, Inc. |
| ADIL | Adial Pharmaceuticals, Inc. |
| CERO | CERo Therapeutics Holdings, Inc. |
| APRE | Aprea Therapeutics, Inc. |
| BCDA | BioCardia, Inc. |
| CDIO | Cardio Diagnostics Holdings, Inc. |